Statement: 7 February 2023
In December 2022, MHRA issued new safety advice on risks associated with valproate for anyone under 55. We are reviewing the valproate recommendations in this guideline and plan to consult on our update proposals shortly. People currently taking valproate should not stop taking it unless they are advised by a specialist to do so.
If you have any questions about this work, please e-mail bipolarreview23@nice.org.uk
Please note that this work is not following the standard Guidelines Manual.